United Kingdom· GB-APID-28697411000001107
Moxifloxacin 400mg tablets
A moxifloxacin product containing moxifloxacin, registered in United Kingdom by Rivopharm (UK) Ltd. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Moxifloxacin is registered in 16 of 19 countries.
Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Moxifloxacin · ATC J01MA14
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of moxifloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Moxifloxacin · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.89
- IT Italy$1.99
- US United States$1.34 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Moxifloxacin
- Manufacturer
- Rivopharm (UK) Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01MA14
- ATC class
- Moxifloxacin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5060388650230
- gtin05060388650230
- gtin5060388650742
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
531 interactions on record for moxifloxacin.
Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moxifloxacin · interactions on record
531 records
- 175 severe
- 140 moderate
- 49 minor
- 92 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
75 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Moxifloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAPO-MOXIFLOXACINAPOTEX INC
- NorwayAveloxBayer AS
- United StatesMoxifloxacinHp Halden Pharma AS
- SpainABIMOX 5 MG/ML COLIRIO EN SOLUCIONTiedra Farmaceutica S.L.
- GermanyAvaloxBayer Vital Gmbh
- PolandFlomixaFarmak International Sp. z o.o.
- CzechiaAVELOXBayer AG, Leverkusen
- FinlandActiraBayer HealthCare AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Avelox, Moxifloxacin 1a Pharma
- Belgium · Avelox, Kanavig
- Bulgaria · Cimocinox, Moxifloxacin Kabi
- Cyprus · Avelox, Erelan
- Czechia · Avelox, Moxifloxacin Brown & Burk
- Germany · Avalox, Moxifloxacin 1 A Pharma
- Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
- Estonia · Avelox, Floxelan
- Spain · Abimox, Actira
- Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- France · Izilox, Moxifloxacine Arrow
- Greece · Avelox, Mikrobiel
- Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
- Hungary · Moxibiot, Moxifloxacin Anfarm
- Ireland · Moxifloxacin
- Iceland · Vigamox
- Italy · Avalox, Moxidrop
- Lithuania · Avelox, Ekara
- Luxembourg · Avelox, Kanavig
- Latvia · Avelox, Ekara
- Malta · Erelan, Moxifloxacin Anfarm
- Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
- Norway · Xinaflox
- Poland · Flomixa, Floxamic Neo
- Portugal · Avelox, Bluesar
- Romania · Avelox, Kimoks
- Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
- Slovenia · Kimoks, Moksifloksacin Kabi
- Slovakia · Avelox, Moloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe4bf48d-741b-497d-b895-d216961fbcc4 GET /v1/drugs/fe4bf48d-741b-497d-b895-d216961fbcc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "28697411000001107",
"desc": "Moxifloxacin 400mg tablets (Rivopharm (UK) Ltd)",
"form": "Oral tablet",
"vpid": "41952411000001107",
"source": "dmd",
"vtm_id": "776831003",
"strength": "400 mg",
"substance": "Moxifloxacin",
"ingredient": "Moxifloxacin hydrochloride",
"supplier_code": "28601711000001107"
}See everything about moxifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.